Joint Transnational Call (JTC2009)
- CAV-4-MPS: Understanding and treating neurodegeneration caused by mucopolysaccharidoses
- Cure-FXS: Targeting Rho-signalling, a new therapeutic avenue in fragile X syndrome
- EB: Identification of revertant mosaicism in epidermolysis bullosa and subsequently using the revertant keratinocytes in a pre-clinical mouse model suitable to test revertant cell therapy
- ELA2-CN: Congenital neutropenia with ELA-2 mutations (ELA2-CN): Identification of (epi)genetic co-factors and molecular pathways underlying clinical heterogeneity
- EMINA: European Multidisciplinary Initiative on Neuroacanthocytosis
- EuPAPNet: European pulmonary alveolar proteinosis network : molecular determinants of causes, variability and outcome
- EURO-CDG: Genetics and pathogenesis of chronic granulomatous disease and development of new gene transfer therapeutic approaches
- EuroGeBeta: European network on genetics, pathophysiology and translational research into rare pancreatic beta-cell insufficiency diseases
- GETHERTHAL: Improvements of vector technology and safety for the gene therapy of thalassemia
- HMA-IRON: Towards improved diagnosis and treatment of rare inherited microcytic hypochromic anemias related to iron metabolism
- MLC-Teams: Megalencephalic leukoencephalopathy with subcortical cysts: from molecular basis to search for therapy
- NEMMYOP: Functional characterization of nemaline myopathy in a murine model with nebulin mutation: moving from basic understanding towards therapeutic interventions
- NEUTRO-NET: Inherited inhibition of inborn immunity – an integrated molecular genetic approach to discover novel human gene defects
- NsEuroNet: European network on noonan syndrome and related disorders
- RHORCOD: Comprehensive analysis of rod-cone photoreceptor degeneration associated with rhodopsin gene mutations